The impact of COVID-19 on the pharmaceutical supply chain in Egypt: The case of Pharco Group

ABSTRACT

The COVID-19 pandemic is regarded as the major disruptive event of this decade, resulting in unexpected socio-economic impacts worldwide. The COVID-19 pandemic has caused considerable damage to various industries worldwide. Availability and supply of a wide range of raw materials, intermediate goods, and finished products have been seriously disrupted. The magnitude of the COVID-19 pandemic has had an enormous impact on the health system and pharmaceutical industry in almost every country globally. This new virus has resulted in pharmaceutical organizations experiencing unprecedented logistical restrictions as a result of increasing demand and limited capacity. Accordingly, this case study assesses the impact of the COVID-19 pandemic on the supply chain (SC) integration of the pharmaceutical sector in Egypt. A case study technique was used for better understating of the situation and to analyze the industry's position and its capabilities to face the consequences of the pandemic, which hindered the integration along the supply chain. © 2023 by IGI Global. All rights reserved.